Market Overview: The global market for kidney fibrosis treatment reached a value of USD 1.38 billion in 2022, and it is anticipated to reach USD 2.05 billion by 2032, demonstrating a robust compound annual growth rate (CAGR) of 4.5% throughout the forecast period. This growth is primarily driven by the increasing prevalence of renal fibrosis, a rise in Research & Development (R&D)...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek